Cargando…

GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer

Detalles Bibliográficos
Autores principales: Mei, Jie, Cai, Yun, Jiang, Guanyu, He, Zhao, Wang, Ruixin, Song, Chenghu, Wan, Yuan, Mao, Wenjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424388/
https://www.ncbi.nlm.nih.gov/pubmed/37574551
http://dx.doi.org/10.1186/s12967-023-04415-w
_version_ 1785089665695481856
author Mei, Jie
Cai, Yun
Jiang, Guanyu
He, Zhao
Wang, Ruixin
Song, Chenghu
Wan, Yuan
Mao, Wenjun
author_facet Mei, Jie
Cai, Yun
Jiang, Guanyu
He, Zhao
Wang, Ruixin
Song, Chenghu
Wan, Yuan
Mao, Wenjun
author_sort Mei, Jie
collection PubMed
description
format Online
Article
Text
id pubmed-10424388
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104243882023-08-15 GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer Mei, Jie Cai, Yun Jiang, Guanyu He, Zhao Wang, Ruixin Song, Chenghu Wan, Yuan Mao, Wenjun J Transl Med Letter to the Editor BioMed Central 2023-08-13 /pmc/articles/PMC10424388/ /pubmed/37574551 http://dx.doi.org/10.1186/s12967-023-04415-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Mei, Jie
Cai, Yun
Jiang, Guanyu
He, Zhao
Wang, Ruixin
Song, Chenghu
Wan, Yuan
Mao, Wenjun
GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer
title GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer
title_full GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer
title_fullStr GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer
title_full_unstemmed GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer
title_short GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer
title_sort gprc5d as a promising therapeutic target in egfr-wild and immuno-cold non-small cell lung cancer
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424388/
https://www.ncbi.nlm.nih.gov/pubmed/37574551
http://dx.doi.org/10.1186/s12967-023-04415-w
work_keys_str_mv AT meijie gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer
AT caiyun gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer
AT jiangguanyu gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer
AT hezhao gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer
AT wangruixin gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer
AT songchenghu gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer
AT wanyuan gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer
AT maowenjun gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer